Oligonucleotide Polymer Conjugates for Multiplex IHC Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for multiplex immunohistochemistry (MIHC) in formalin-fixed, paraffin-embedded tissues lack efficient and reproducible techniques for simultaneous and quantitative detection of multiple protein targets, often suffering from interference and reduced antibody activity due to steric effects and background noise.

Innovation Solution

Development of polymers comprising oligonucleotide sequences with specific spacers and linkers, coupled with labels such as haptens or fluorophores, which allow for precise spacing and minimal interference, enabling multiple target detection without compromising antibody activity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If multiple labels are attached to detect multiple protein targets simultaneously, then the detection capability is improved, but steric effects and background noise increase causing interference

Engineering Contradiction:
Improvedetection capabilityVSAvoidsteric effects and background noise
Core Design Contradiction:
Adaptability or versatilityVSObject-affected harmful factors

Solution Approach 1:

The invention divides the detection system into separate detection cycles, where each label is detected sequentially rather than simultaneously. This temporal segmentation eliminates steric interference between multiple labels and reduces background noise, while still enabling multiplex detection of multiple protein targets through repeated imaging cycles with different fluorescence channels.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention employs periodic detection cycles that systematically activate different fluorescence channels in sequence. By periodically switching between detection modes for different labels, the system achieves multiplex detection capability while minimizing interference, as each label is detected during its designated time window without competing with other labels.

Inventive Principle:
Principle #19Periodic action

2Ease of manufacture

If conventional IHC methods are used for multiplex detection, then the methodology is simple, but the efficiency and reproducibility for simultaneous quantitative detection of multiple targets are insufficient

Engineering Contradiction:
Improvemethodology simplicityVSAvoiddetection efficiency
Core Design Contradiction:
Ease of manufactureVSProductivity

Solution Approach 1:

The invention creates a universal multiplex IHC platform that can detect multiple protein targets simultaneously using a standardized workflow. The system employs universal reagents (polymer-conjugated antibodies, tyramide substrates) and a consistent cyclic detection protocol that can be applied to any combination of targets, thereby improving detection efficiency and reproducibility while maintaining methodological simplicity through standardization.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The invention changes the temporal parameter of detection by implementing cyclic, time-separated detection of different labels. This parameter change from simultaneous to sequential detection resolves the contradiction by enabling efficient multiplex detection without the interference that plagues conventional methods, while the standardized cyclic protocol maintains ease of implementation.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If polymer conjugates with multiple labels are used, then sensitivity is improved, but antibody activity is compromised due to steric effects

Engineering Contradiction:
ImprovesensitivityVSAvoidantibody activity
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The invention makes the detection system dynamic by implementing sequential detection cycles rather than static simultaneous detection. This allows the antibody-conjugate system to maintain its binding activity while achieving high sensitivity through signal amplification during each cycle, as the dynamic temporal separation prevents steric interference that would otherwise compromise antibody function.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The invention performs preliminary signal amplification through tyramide deposition before final detection. This preliminary action allows the use of polymer conjugates with multiple labels to enhance sensitivity, as the amplified signal from each binding event compensates for any reduced antibody activity, while the cyclic detection protocol prevents steric interference during the actual binding process.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS12553886B2Polymers and conjugates comprising the same
Publication Date: 2026.02.17 VENTANA MEDICAL SYSTEMS INC
  • US12553886B2 patent drawing
  • US12553886B2 patent drawing
  • US12553886B2 patent drawing

AI summary

Polymers and conjugates comprising polymers are disclosed herein. In some embodiments, the conjugates disclosed are suitable for use as detection probes in immunohistochemical assays, including multiplex immunohistochemical assays.